Keywords: alza, ditropan, xl, vs, immediate-release, form, data

Alza's Ditropan XL vs immediate-release form

Article | 28 May 1999

Print This

Data from a pivotal Phase III trial of Alza's Ditropan XL (oxybutyninchloride) have shown that the extended release formulation is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in